KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 56 filers reported holding KINNATE BIOPHARMA INC in Q1 2024. The put-call ratio across all filers is 9.51 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $10,911 | -63.2% | 4,102 | -67.3% | 0.00% | – |
| Q4 2023 | $29,689 | -51.5% | 12,527 | -71.3% | 0.00% | – |
| Q3 2023 | $61,202 | -81.8% | 43,716 | -60.6% | 0.00% | -100.0% |
| Q2 2023 | $336,063 | +199.6% | 110,912 | +503.2% | 0.00% | +100.0% |
| Q4 2022 | $112,155 | -8.8% | 18,386 | +78.2% | 0.00% | 0.0% |
| Q3 2022 | $123,000 | -27.2% | 10,315 | +40.1% | 0.00% | -50.0% |
| Q3 2021 | $169,000 | – | 7,361 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|